Header Logo

Connection

NANCY DUGAL PERRIER to Prognosis

Back to Details
This is a "connection" page, showing publications NANCY DUGAL PERRIER has written about Prognosis.
NANCY DUGAL PERRIER
Connection Strength
0.640
Prognosis
  1. Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Manual for Adrenocortical Carcinoma. World J Surg. 2020 02; 44(2):544-551.
    View in: PubMed
    Score: 0.052
  2. ASO Author Reflections: Distant Metastatic Parathyroid Carcinoma-Has the "Train Left the Station?" Ann Surg Oncol. 2019 Oct; 26(11):3600-3601.
    View in: PubMed
    Score: 0.050
  3. Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center. Ann Surg Oncol. 2019 Oct; 26(11):3593-3599.
    View in: PubMed
    Score: 0.049
  4. ASO Author Reflections: PTTG1 Protein Expression in Adrenocortical Carcinoma. Ann Surg Oncol. 2019 Dec; 26(Suppl 3):533-534.
    View in: PubMed
    Score: 0.048
  5. From Initial Description by Wermer to Present-Day MEN1: What have We Learned? World J Surg. 2018 04; 42(4):1031-1035.
    View in: PubMed
    Score: 0.045
  6. Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2018 01; 68(1):55-63.
    View in: PubMed
    Score: 0.044
  7. American Joint Committee on Cancer: Endocrine Surgery. Ann Surg Oncol. 2017 May; 24(5):1151-1152.
    View in: PubMed
    Score: 0.042
  8. Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center. Horm Cancer. 2016 08; 7(4):279-87.
    View in: PubMed
    Score: 0.040
  9. A Calculating Device to Predict Individualized Outcomes in Adrenocortical Carcinoma. JAMA Surg. 2016 Apr; 151(4):373.
    View in: PubMed
    Score: 0.039
  10. The role of thyroidectomy in metastatic disease to the thyroid gland. Ann Surg Oncol. 2014 Feb; 21(2):434-9.
    View in: PubMed
    Score: 0.033
  11. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy. Ann Surg Oncol. 2009 Nov; 16(11):3146-53.
    View in: PubMed
    Score: 0.025
  12. Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg. 2005 Nov; 242(5):642-50.
    View in: PubMed
    Score: 0.019
  13. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma. J Clin Endocrinol Metab. 2023 04 13; 108(5):1132-1142.
    View in: PubMed
    Score: 0.016
  14. A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression. J Clin Endocrinol Metab. 2021 11 19; 106(12):e4969-e4980.
    View in: PubMed
    Score: 0.015
  15. Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature. Endocr Relat Cancer. 2020 06; 27(6):R145-R161.
    View in: PubMed
    Score: 0.013
  16. Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in?sporadic medullary thyroid carcinoma. Surgery. 2020 01; 167(1):80-86.
    View in: PubMed
    Score: 0.013
  17. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions. Thyroid. 2018 10; 28(10):1301-1310.
    View in: PubMed
    Score: 0.012
  18. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma. Ann Surg Oncol. 2018 Mar; 25(3):801-807.
    View in: PubMed
    Score: 0.011
  19. Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: A single-centre study, systematic review and meta-analysis. Clin Endocrinol (Oxf). 2017 Dec; 87(6):706-716.
    View in: PubMed
    Score: 0.011
  20. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. J Clin Endocrinol Metab. 2017 08 01; 102(8):2807-2813.
    View in: PubMed
    Score: 0.011
  21. Endocrine incidentalomas. Curr Probl Surg. 2016 May; 53(5):219-46.
    View in: PubMed
    Score: 0.010
  22. Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB). Ann Surg Oncol. 2015 Nov; 22(12):3990-5.
    View in: PubMed
    Score: 0.009
  23. Surgical resection of synchronously metastatic adrenocortical cancer. Ann Surg Oncol. 2015 Jan; 22(1):146-51.
    View in: PubMed
    Score: 0.009
  24. Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome. Surgery. 2012 Jun; 151(6):851-9.
    View in: PubMed
    Score: 0.007
  25. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011 Mar; 96(3):717-25.
    View in: PubMed
    Score: 0.007
  26. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. Surgery. 2007 Dec; 142(6):867-75; discussion 867-75.
    View in: PubMed
    Score: 0.006
  27. The scintigraphic appearance of subcapsular parathyroid adenomas. Clin Nucl Med. 2005 Apr; 30(4):213-7.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.